X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-11 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $46.10 | -277 | 1,599,297 | 0% | -$12,771 | |||||
| D | 2024-10-07 | MRNA | Mock James M | CFO | S - Sale+OE | $60.12 | -715 | 9,505 | -7% | -$42,986 | |||||
| D | 2024-09-09 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $73.57 | -551 | 18,154 | -3% | -$40,539 | |||||
| D | 2024-09-03 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $76.99 | -114 | 17,566 | -1% | -$8,777 | |||||
| D | 2024-09-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $76.99 | -318 | 1,599,051 | 0% | -$24,483 | |||||
| D | 2024-08-29 | MRNA | Mock James M | CFO | S - Sale+OE | $78.03 | -162 | 8,767 | -2% | -$12,640 | |||||
| D | 2024-08-29 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $78.03 | -162 | 17,447 | -1% | -$12,640 | |||||
| D | 2024-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.03 | -300 | 1,598,717 | 0% | -$23,408 | |||||
| D | 2024-08-28 | MRNA | Mock James M | CFO | S - Sale+OE | $79.39 | -1,321 | 8,600 | -13% | -$104,881 | |||||
| D | 2024-08-28 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $79.39 | -1,319 | 17,280 | -7% | -$104,722 | |||||
| D | 2024-08-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $84.10 | -254 | 1,598,406 | 0% | -$21,363 | |||||
2024-07-31 | MRNA | Afeyan Noubar | Dir | S - Sale | $119.96 | -15,000 | 6,856,164 | 0% | -$1,799,443 | ||||||
2024-07-24 | MRNA | Afeyan Noubar | Dir | S - Sale | $117.80 | -15,000 | 6,871,164 | 0% | -$1,766,972 | ||||||
2024-07-17 | MRNA | Afeyan Noubar | Dir | S - Sale | $122.84 | -15,000 | 6,886,164 | 0% | -$1,842,651 | ||||||
2024-07-15 | MRNA | Hoge Stephen | Pres | S - Sale | $121.12 | -15,000 | 1,598,138 | -1% | -$1,816,800 | ||||||
2024-07-10 | MRNA | Afeyan Noubar | Dir | S - Sale | $117.08 | -15,000 | 6,901,164 | 0% | -$1,756,177 | ||||||
| D | 2024-07-08 | MRNA | Mock James M | CFO | S - Sale+OE | $118.24 | -689 | 7,269 | -9% | -$81,465 | |||||
2024-06-26 | MRNA | Afeyan Noubar | Dir | S - Sale | $127.22 | -15,000 | 6,916,164 | 0% | -$1,908,293 | ||||||
2024-06-18 | MRNA | Afeyan Noubar | Dir | S - Sale | $133.57 | -15,000 | 6,931,164 | 0% | -$2,003,561 | ||||||
2024-06-17 | MRNA | Hoge Stephen | Pres | S - Sale | $138.16 | -15,000 | 1,613,138 | -1% | -$2,072,400 | ||||||
2024-06-12 | MRNA | Afeyan Noubar | Dir | S - Sale | $147.21 | -15,000 | 6,946,164 | 0% | -$2,208,071 | ||||||
2024-06-11 | MRNA | Afeyan Noubar | Dir | S - Sale | $148.34 | -202,832 | 11,410,137 | -2% | -$30,087,339 | ||||||
| D | 2024-06-10 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $148.09 | -5,178 | 15,947 | -25% | -$766,785 | |||||
2024-06-05 | MRNA | Afeyan Noubar | Dir | S - Sale | $151.25 | -15,000 | 11,612,969 | 0% | -$2,268,804 | ||||||
| D | 2024-06-03 | MRNA | Mock James M | CFO | S - Sale+OE | $140.72 | -691 | 6,506 | -10% | -$97,237 | |||||
| D | 2024-06-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.72 | -339 | 1,628,138 | 0% | -$47,704 | |||||
| D | 2024-06-03 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $140.72 | -122 | 10,878 | -1% | -$17,168 | |||||
2024-05-29 | MRNA | Afeyan Noubar | Dir | S - Sale | $145.08 | -20,000 | 11,627,969 | 0% | -$2,901,585 | ||||||
| D | 2024-05-29 | MRNA | Mock James M | CFO | S - Sale+OE | $144.51 | -183 | 5,871 | -3% | -$26,444 | |||||
| D | 2024-05-29 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $144.51 | -183 | 10,768 | -2% | -$26,444 | |||||
| D | 2024-05-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $144.51 | -341 | 1,627,826 | 0% | -$49,276 | |||||
| D | 2024-05-28 | MRNA | Mock James M | CFO | S - Sale+OE | $162.47 | -648 | 5,726 | -10% | -$105,283 | |||||
| D | 2024-05-28 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $162.47 | -1,296 | 10,623 | -11% | -$210,566 | |||||
2024-05-22 | MRNA | Afeyan Noubar | Dir | S - Sale | $157.57 | -15,000 | 11,647,969 | 0% | -$2,363,556 | ||||||
2024-05-15 | MRNA | Afeyan Noubar | Dir | S - Sale | $127.32 | -15,000 | 11,662,969 | 0% | -$1,909,863 | ||||||
2024-05-15 | MRNA | Hoge Stephen | Pres | S - Sale | $127.49 | -15,000 | 1,627,557 | -1% | -$1,912,350 | ||||||
| D | 2024-05-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $120.96 | -255 | 1,642,557 | 0% | -$30,844 | |||||
2024-05-08 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.68 | -15,000 | 11,677,969 | 0% | -$1,825,220 | ||||||
2024-05-01 | MRNA | Afeyan Noubar | Dir | S - Sale | $110.92 | -15,000 | 11,692,969 | 0% | -$1,663,855 | ||||||
2024-04-24 | MRNA | Afeyan Noubar | Dir | S - Sale | $108.32 | -15,000 | 11,707,969 | 0% | -$1,624,836 | ||||||
2024-04-17 | MRNA | Afeyan Noubar | Dir | S - Sale | $103.38 | -15,000 | 11,722,969 | 0% | -$1,550,703 | ||||||
2024-04-15 | MRNA | Hoge Stephen | Pres | S - Sale | $105.02 | -15,000 | 1,642,290 | -1% | -$1,575,300 | ||||||
2024-04-10 | MRNA | Afeyan Noubar | Dir | S - Sale | $107.12 | -15,000 | 11,737,969 | 0% | -$1,606,865 | ||||||
| D | 2024-04-08 | MRNA | Mock James M | CFO | S - Sale+OE | $101.93 | -705 | 5,048 | -12% | -$71,859 | |||||
2024-04-03 | MRNA | Afeyan Noubar | Dir | S - Sale | $101.69 | -15,000 | 11,752,969 | 0% | -$1,525,268 | ||||||
2024-03-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $109.06 | -15,000 | 11,767,969 | 0% | -$1,635,864 | ||||||
2024-03-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $102.39 | -15,000 | 11,782,969 | 0% | -$1,535,820 | ||||||
2024-03-15 | MRNA | Hoge Stephen | Pres | S - Sale | $103.17 | -15,000 | 1,657,290 | -1% | -$1,547,550 | ||||||
2024-03-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $108.54 | -15,000 | 11,797,969 | 0% | -$1,628,031 | ||||||
| D | 2024-03-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $99.05 | -544 | 9,267 | -6% | -$53,884 | |||||
| D | 2024-03-04 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $94.34 | -117 | 8,673 | -1% | -$11,038 | |||||
| D | 2024-03-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.34 | -309 | 1,672,290 | 0% | -$29,151 | |||||
| D | 2024-02-29 | MRNA | Mock James M | CFO | S - Sale+OE | $94.57 | -647 | 4,300 | -13% | -$61,188 | |||||
| D | 2024-02-29 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $94.57 | -670 | 8,557 | -7% | -$63,363 | |||||
| D | 2024-02-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.57 | -2,388 | 1,671,947 | 0% | -$225,838 | |||||
2024-02-22 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15,000 | 1,669,482 | -1% | -$1,500,000 | ||||||
2024-02-16 | MRNA | Hoge Stephen | Pres | S - Sale | $88.88 | -10,542 | 1,684,482 | -1% | -$936,981 | ||||||
2024-02-16 | MRNA | Bancel Stephane | CEO | S - Sale | $88.88 | -26,351 | 21,075,476 | 0% | -$2,342,098 | ||||||
| D | 2024-02-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $86.23 | -304 | 1,672,330 | 0% | -$26,214 | |||||
2024-01-16 | MRNA | Hoge Stephen | Pres | S - Sale | $103.90 | -15,000 | 1,672,112 | -1% | -$1,558,500 | ||||||
| D | 2024-01-08 | MRNA | Mock James M | CFO | S - Sale+OE | $109.76 | -772 | 3,632 | -18% | -$84,731 | |||||
2023-12-27 | MRNA | Hoge Stephen | Pres | S - Sale | $100.01 | -45,000 | 1,687,112 | -3% | -$4,500,450 | ||||||
| D | 2023-12-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $79.09 | -563 | 7,912 | -7% | -$44,525 | |||||
| D | 2023-12-06 | MRNA | Garay Arpa | Chief Commercial Officer | S - Sale+OE | $78.34 | -564 | 3,690 | -13% | -$44,182 | |||||
| D | 2023-12-04 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $79.31 | -111 | 7,336 | -1% | -$8,804 | |||||
| D | 2023-12-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.31 | -309 | 1,732,112 | 0% | -$24,508 | |||||
| D | 2023-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.81 | -1,136 | 1,731,770 | 0% | -$90,666 | |||||
| D | 2023-11-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $68.76 | -263 | 1,730,495 | 0% | -$18,084 | |||||
2023-11-01 | MRNA | Afeyan Noubar | Dir | S - Sale | $76.00 | -10,000 | 11,812,969 | 0% | -$760,032 | ||||||
2023-10-25 | MRNA | Afeyan Noubar | Dir | S - Sale | $76.99 | -10,000 | 11,822,969 | 0% | -$769,854 | ||||||
2023-10-11 | MRNA | Afeyan Noubar | Dir | S - Sale | $103.30 | -15,000 | 11,832,969 | 0% | -$1,549,441 | ||||||
| D | 2023-10-06 | MRNA | Mock James M | CFO | S - Sale+OE | $102.50 | -2,858 | 2,952 | -49% | -$292,953 | |||||
2023-10-04 | MRNA | Afeyan Noubar | Dir | S - Sale | $102.72 | -15,000 | 11,847,969 | 0% | -$1,540,845 | ||||||
2023-09-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $98.96 | -10,000 | 11,862,969 | 0% | -$989,646 | ||||||
2023-09-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $104.74 | -15,000 | 11,872,969 | 0% | -$1,571,090 | ||||||
2023-09-15 | MRNA | Hoge Stephen | Pres | S - Sale | $112.99 | -15,000 | 1,730,236 | -1% | -$1,694,850 | ||||||
2023-09-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $109.70 | -15,000 | 11,887,969 | 0% | -$1,645,522 | ||||||
| D | 2023-09-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $107.22 | -557 | 7,215 | -7% | -$59,722 | |||||
2023-09-06 | MRNA | Afeyan Noubar | Dir | S - Sale | $107.61 | -15,000 | 14,868,952 | 0% | -$1,614,094 | ||||||
| D | 2023-09-06 | MRNA | Garay Arpa | Chief Commercial Officer | S - Sale+OE | $108.40 | -574 | 3,113 | -16% | -$62,219 | |||||
| D | 2023-09-05 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $111.44 | -115 | 6,634 | -2% | -$12,815 | |||||
| D | 2023-09-05 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $111.44 | -320 | 1,745,236 | 0% | -$35,660 | |||||
2023-08-30 | MRNA | Afeyan Noubar | Dir | S - Sale | $115.46 | -15,000 | 14,883,952 | 0% | -$1,731,951 | ||||||
| D | 2023-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $115.02 | -1,135 | 1,744,904 | 0% | -$130,542 | |||||
2023-08-23 | MRNA | Afeyan Noubar | Dir | S - Sale | $115.51 | -15,000 | 14,898,952 | 0% | -$1,732,613 | ||||||
2023-08-16 | MRNA | Afeyan Noubar | Dir | S - Sale | $97.56 | -10,000 | 14,913,952 | 0% | -$975,614 | ||||||
2023-08-17 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15,000 | 1,743,628 | -1% | -$1,500,000 | ||||||
| D | 2023-08-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $102.53 | -247 | 1,758,628 | 0% | -$25,325 | |||||
2023-08-02 | MRNA | Afeyan Noubar | Dir | S - Sale | $110.99 | -15,000 | 14,923,952 | 0% | -$1,664,876 | ||||||
2023-07-26 | MRNA | Afeyan Noubar | Dir | S - Sale | $120.42 | -15,000 | 14,938,952 | 0% | -$1,806,229 | ||||||
2023-07-19 | MRNA | Afeyan Noubar | Dir | S - Sale | $125.48 | -15,000 | 14,953,952 | 0% | -$1,882,152 | ||||||
2023-07-17 | MRNA | Hoge Stephen | Pres | S - Sale | $120.60 | -15,000 | 1,758,352 | -1% | -$1,809,000 | ||||||
2023-07-12 | MRNA | Afeyan Noubar | Dir | S - Sale | $125.81 | -15,000 | 14,968,952 | 0% | -$1,887,081 | ||||||
2023-07-05 | MRNA | Afeyan Noubar | Dir | S - Sale | $124.73 | -15,000 | 14,983,952 | 0% | -$1,870,933 | ||||||
2023-06-28 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.54 | -15,000 | 14,998,952 | 0% | -$1,823,160 | ||||||
| D | 2023-06-28 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $121.63 | -27,155 | 21,027,198 | 0% | -$3,302,907 | |||||
2023-06-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.95 | -15,000 | 15,013,952 | 0% | -$1,829,227 | ||||||
| DM | 2023-06-21 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $120.70 | -80,000 | 21,027,198 | 0% | -$9,655,714 | |||||
2023-06-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $126.18 | -15,000 | 15,028,952 | 0% | -$1,892,627 | ||||||
| DM | 2023-06-14 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $127.27 | -80,000 | 21,027,198 | 0% | -$10,181,874 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |